Telix Pharmaceuticals (Innovations) Pty Limited

Telix Pharmaceuticals (Innovations) Pty Limited focuses its clinical research on aggressive primary brain tumours, with a particular emphasis on glioblastoma and glioblastoma multiforme. The studies it supports are centred on patients with newly diagnosed disease and those with recurrent disease.

• Recurrent glioblastoma
• Newly diagnosed glioblastoma
• Glioblastoma multiforme (GBM)

The sponsor’s trial portfolio reflects sustained interest in treatment settings where disease control and survival outcomes remain major clinical challenges.